Curanex regains Nasdaq compliance after reverse stock split
Curanex Pharmaceuticals regained Nasdaq compliance after a 1-for-20 reverse stock split restored its $1.00 minimum bid price.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.